Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Comprehensive Management of ANOCA, Part 2-Program Development, Treatment, and Research Initiatives: JACC State-of-the-Art Review. Journal of the American College of Cardiology Smilowitz, N. R., Prasad, M., Widmer, R. J., Toleva, O., Quesada, O., Sutton, N. R., Lerman, A., Reynolds, H. R., Kesarwani, M., Savage, M. P., Sweeny, J. M., Janaszek, K. B., Barseghian El-Farra, A., Holoshitz, N., Park, K., Albadri, A., Blair, J. A., Jeremias, A., Kearney, K. E., Kobayashi, Y., Miner, S. E., Samuels, B. A., Shah, S. M., Taqueti, V. R., Wei, J., Fearon, W. F., Moses, J. W., Henry, T. D., Tremmel, J. A. 2023; 82 (12): 1264-1279

Abstract

Centers specializing in coronary function testing are critical to ensure a systematic approach to the diagnosis and treatment of angina with nonobstructive coronary arteries (ANOCA). Management leveraging lifestyle, pharmacology, and device-based therapeutic options for ANOCA can improve angina burden and quality of life in affected patients. Multidisciplinary care teams that can tailor and titrate therapies based on individual patient needs are critical to the success of comprehensive programs. As coronary function testing for ANOCA is more widely adopted, collaborative research initiatives will be fundamental to improve ANOCA care. These efforts will require standardized symptom assessments and data collection, which will propel future large-scale clinical trials.

View details for DOI 10.1016/j.jacc.2023.06.044

View details for PubMedID 37704316